Nurse Practitioner, Family · Poplar Bluff, MO
NPI
1316486202
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
225 Physicians Park, Ste 203
Poplar Bluff, MO, 63901
Phone (573) 686-4750
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
2,259 services
Medicare patients, 2024
436
Average age 74
Drug cost, 2024
$1.9M
843 prescriptions
Company payments, 2025
$1,405
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vanessa Adams was code 17003 (destruction skin lesion), 645 times for 91 patients. In total Vanessa Adams billed 2,259 services in 26 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 645 | 91 | $3.58 | $2,306 |
| 99213 Office E&M - Established | Office | 560 | 299 | $47.10 | $26K |
| 17000 Destruction Skin Lesion | Office | 295 | 157 | $28.99 | $8,552 |
| 17110 Destruction Skin Lesion | Office | 216 | 135 | $57.86 | $12K |
| 99214 Office E&M - Established | Office | 133 | 67 | $70.00 | $9,309 |
| 99203 Office E&M - New | Office | 90 | 90 | $55.12 | $4,961 |
| 11102 Skin Biopsy | Office | 82 | 77 | $44.30 | $3,633 |
| 99212 Office E&M - Established | Office | 75 | 63 | $27.97 | $2,098 |
| 99202 Office E&M - New | Office | 29 | 29 | $33.38 | $968 |
| 17004 Destruction Skin Lesion | Office | 21 | 13 | $95.90 | $2,014 |
| 11104 Skin Biopsy | Office | 15 | 14 | $54.55 | $818 |
| 11103 Skin Biopsy | Office | 15 | 11 | $25.83 | $387 |
| 17111 Destruction Skin Lesion | Office | 14 | 11 | $59.52 | $833 |
By year: 2022 $109K for 7,705 services; 2023 $90K for 10,355 services; 2024 $80K for 2,259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vanessa Adams prescribed most often to Medicare patients was Triamcinolone Acetonide, with 136 prescriptions and refills. In total Vanessa Adams wrote 843 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 136 | 144 | 85 | $979 |
| Ketoconazole Generic | 128 | 130 | 48 | $1,680 |
| Mupirocin Generic | 60 | 60 | 39 | $545 |
| Clobetasol Propionate Generic | 53 | 54 | 28 | $2,290 |
| Otezla Apremilast | 51 | 51 | Under 11 | $241K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 41 | 47 | Under 11 | $401K |
| Dupixent Syringe Dupilumab | 39 | 39 | Under 11 | $159K |
| Tretinoin Generic | 36 | 36 | 22 | $1,582 |
| Mometasone Furoate Generic | 36 | 37 | 13 | $620 |
| Doxycycline Hyclate Generic | 29 | 29 | 21 | $236 |
| Skyrizi Risankizumab-Rzaa | 27 | 76 | Under 11 | $606K |
| Ammonium Lactate Generic | 23 | 30 | 19 | $310 |
| Ciclopirox Generic | 15 | 15 | Under 11 | $272 |
| Stelara Ustekinumab | 11 | 31 | Under 11 | $162K |
| Metronidazole Generic | 11 | 11 | Under 11 | $719 |
Brand drugs: 223 claims; generic drugs: 620 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vanessa Adams $1,405 ($1,405 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $265.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $265 |
| Janssen Biotech, Inc. JNJ | 15 | $205 |
| LEO Pharma Inc. | 8 | $185 |
| Lilly USA, LLC LLY | 9 | $176 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $114 |
| Genzyme Corporation SNY | 4 | $83.55 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $65.36 |
| UCB, Inc. UCB.BR | 2 | $60.44 |
| BioWound Solutions, Inc. | 2 | $53.93 |
| Botanix SB Inc | 3 | $51.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.